AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2018
Feb 22, 2018
30339_dirs_2018-02-22_3574ea34-6308-4651-bc5e-b73694dcc0f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2018-02-20
Reporting Person: Flynn Karen (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-20 | Stock Options (Right to buy) | $89.64 | A | 17544.00 | Acquired | 2028-02-20 | Common Stock (17544.00) | Direct |
Footnotes
F1: This award vests in 4 equal annual installments beginning on 2/20/2019
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12